TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Concentration of test compound required for inhibition of binding of rHsp90 in MCF-7 cell lysateMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Concentration of test compound required for inhibition of binding of rHsp90 in MCF-7 cell lysateMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Concentration of test compound required for half-maximal inhibition of binding of Heat shock 90 KD protein by MCF-7 cell lysate assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Concentration of test compound required for inhibition of binding of rHsp90 in MCF-7 cell lysateMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Concentration of test compound required for inhibition of binding of rHsp90 in MCF-7 cell lysateMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Concentration of test compound required for inhibition of binding of rHsp90 in MCF-7 cell lysateMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Concentration of test compound required for half-maximal inhibition of binding of Heat shock 90 KD protein by MCF-7 cell lysate assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 55nMAssay Description:Concentration of test compound required for half-maximal inhibition of binding of Heat shock 90 KD protein by MCF-7 cell lysate assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Concentration of test compound required for half-maximal inhibition of binding of Heat shock 90 KD protein by MCF-7 cell lysate assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Concentration of test compound required for half-maximal inhibition of binding of Heat shock 90 KD protein by MCF-7 cell lysate assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 550nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 900nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human epidermal growth factor 2 (Her-2) degredation in MCF-7 cellsMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.30E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.30E+3nMAssay Description:Concentration required to inhibit biotin-GM binding to recombinant heat shock protein 90(rHsp90)More data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Conforma Therapeutics
Curated by ChEMBL
Conforma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Concentration required to inhbit Bis-ANS activity by recombinant heat shock protein 90 (rHSP90) conformational assayMore data for this Ligand-Target Pair